A Phase 4 interventional study of 0.8% Hyaluronic Acid and Scaling and Root Planing in Periodontitis, sponsored by Riyadh Colleges of Dentistry and Pharmacy. Completed at 1 site in Saudi Arabia. Per ClinicalTrials.gov, last updated 2018-03-05.
Sponsored by Riyadh Colleges of Dentistry and Pharmacy · Phase 4, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
assess the clinical and laboratory effects of the local and sub gingival application of a 0.8% hyaluronic acid gel (GENGIGEL®) as an adjunct to scaling and root planning (SRP) in chronic moderate to severe periodontitis patients as indicated by expression of Human Beta Definsin-2 (HBD2) in gingival crevicular fluid (GCF).
Patients who fulfilled the selection criteria will be included in the study. One quadrant will be treated with HA gel (test) and the other without to serve as control. Clinical examination will be done in a dental chair under standard conditions of light, using mouth mirror and graduated Williams Periodontal Probe.
All patients will receive full mouth scaling and root planing with hand instruments and ultrasonic scalers at baseline. Thereafter, in the test quadrant, 1 ml of 0.8% hyaluronic acid gel will be administered subgingivally in all selected test sites at baseline and 1 week later. The following clinical parameters will be recorded at baseline, after 6 weeks and 12 weeks post treatment. Oral hygiene instructions will be given to all patients. The clinical measurements and treatment will be performed by a single examiner.For every patient and control subject, GCF samples will be collected at baseline, 6 weeks and 12 weeks post treatment. The samples will be pooled from two periodontal sites with clinical attachment level of 3 mm or more (in the two different quadrants). The sampling area will be isolated with cotton rolls and carefully will be cleaned supragingivally with sterile cotton pellets. A sterile absorbent paper point will be inserted into the gingival crevice or pocket until resistance will be felt. The paper point will be held in place for 30 s and then will be transferred to a vial containing 100 μL of distilled water and vigorously will be mixed. The paper points will be removed, and the samples will be centrifuged and will be washed twice with distilled water. The resultant pellets will be resuspended in 0.4 mL of distilled water. The samples will be coded and stored at -70 °C until use for ELISA test for identification of Human beta Defensin-2.
1,239 studies on the registry are indexed under Periodontitis; 302 are open to participants now.
This study's enrollment of 24 is below the median of 44 across 848 interventional studies indexed under Periodontitis.
Browse Periodontitis studies →Riyadh Colleges of Dentistry and Pharmacy is the lead sponsor of 28 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Scaling and Root Planing 0.8% Hyaluronic acid gel
Drug: 0.8% Hyaluronic Acid · Procedure: Scaling and Root Planing
Scaling and Root Planing
Procedure: Scaling and Root Planing
Application of 0.8% hyaluronic acid after scaling and root planing
Also known as: Gengigel
Scaling of the teeth using hand and ultrasonic scalers followed by planing of the root with curettes
Clinical Attachment Level (CAL) change
Distance from the cementoenamel junction to the base of gingival sulcus using a UNC15 probe
Time frame: baseline, six weeks, 12 weeks
Probing Depth change
It's the distance from the gingival margin to base of the sulcus
Time frame: baseline, six weeks, 12 weeks
Gingival Index change (Loe and Silness, 1963)
To assess the gingival condition and record qualitative chances in the gingiva
Time frame: baseline, six weeks, 12 weeks
Plaque index change (Loe and Silness, 1964)
To measure the state of oral hygiene
Time frame: baseline, six weeks, 12 weeks
Papillary Bleeding Index change (Muhlemann, 1977)
immediate evaluation of the patient's gingival motivation and condition
Time frame: baseline, six weeks, 12 weeks
HBD-2 change
By take gingival crevicular fluid sample elisa test
Time frame: baseline, six weeks, 12 weeks
Plan to share: No
Ran from Feb 2017 to primary completion in Aug 2017, 6 months.
Of 29 non-industry phase 4 interventional studies under Periodontitis, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 22. This study's 6 months is below that.
Counting every sponsor, half of 30 studies reached it within 11 months; a quarter within 7 and three quarters within 22.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Mar 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Hyaluronic Acid
Riyadh Colleges of Dentistry and Pharmacy